Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (52)
  • 2024 (40)
  • 2023 (76)
  • 2022 (84)
  • 2021 (70)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (587)
  • Synthetic drugs (178)
  • OCDETF/Task Force (175)
  • Fake Pills (167)
  • Arrests/Convictions - Major (152)
  • Guns/Weapons (148)
  • Guilty Plea (85)
  • Seizures (Drugs/Property) (69)
  • Fentanyl Awareness (52)
  • Overdose (42)
  • Take Back Day (41)
  • Outreach/Drug Prevention (38)
  • Diversion Division (36)
  • Major Law Enforcement Operation (36)
  • Money Laundering (35)
  • Gangs (32)
  • One Pill Can Kill (27)
  • Task Forces/Task Force Officers (20)
  • HIDTA (17)
  • Pharmaceuticals/Pharmacists/Physicians (17)
  • Fentanyl Free America (16)
  • Counterfeit Pills (14)
  • Extraditions (12)
  • Narcoterrorism (11)
  • Campaigns (10)
  • Other (9)
  • Press Conferences (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Terrorism (7)
  • Public and Media Affairs - also see Congressional Affairs (6)
  • International/Foreign Operations (4)
  • Intelligence Division - Intelligence Products (3)
  • Critical Incident (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • Red Ribbon (1)
  • Prescription Drugs (52)

Drug Name

  • Fentanyl (4)
  • Oxycodone (4)
  • Cocaine (2)
  • Amphetamines (1)
  • Heroin (1)
  • Hydromorphone (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Methamphetamine (1)

Field Division

  • Louisville (6)
  • San Francisco (5)
  • Seattle (5)
  • Sede (5)
  • New England (4)
  • Washington, DC (4)
  • Los Angeles (3)
  • Miami (3)
  • Omaha (3)
  • Atlanta (2)
  • El Paso (2)
  • New Orleans (2)
  • New York (2)
  • Phoenix (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • St. Louis (1)
Clear All Results
52 Results - Showing 51 to 52
PRESS RELEASE

DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections. In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster